ICI2018

STENTiT’s Regenerative Stent Technology at ICI 2018 in Tel Aviv

STENTiT’s promising first in-vivo data will be presented at the premier international meeting for innovation in cardiovascular systems, ICI 2018 event in Tel Aviv, Israël. Dr. Yoshinobu Onuma MD PhD, from the Erasmus Medical Center of Rotterdam, will present STENTiT’s scientific evidence and clinical applications of the regenerative stent technology in the session; “Stents –[…]

Stentit Feature Image

Slash Magazine Interview with STENTiT

The current edition of Slash magazine features an interesting interview with the founders of STENTiT. In case you want to know more about the past, present and future of STENTiT, please have a look at the full article using the following link. Slash is the alumni- and relation magazine of the Eindhoven University of Technology.[…]

CESUnveiled

HRH Prince Constantijn highlights STENTiT among the 10 Dutch Breakthrough Technologies

This year at CES Unveiled Amsterdam, Special Envoy StartupDelta Constantijn van Oranje announced the 10 Dutch Breakthrough Technologies of 2018. Among the impressive list, STENTiT was proudly highlighted in the field of Regenerative Medicine. The list has been compiled in consultation with leading academics, investors and industry experts to showcase the next big dutch breakthrough[…]

EIT Health

STENTiT Receives EIT Health Funding

The health division from the European Institute of Innovation and Technology (EIT Health), provides financial support to STENTiT from the Headstart Funding Programme. The money is granted to support further product development and market validation of the regenerative stent. EIT Health provides funding for early stage companies and SMEs to develop new products and services.[…]

MITZuid

MIT-Zuid Subsidy for STENTiT

STENTiT obtains financial support from MKB Innovatiestimulering Topsectoren Zuid-Nederland (MIT-Zuid). This program will provide funds to conduct a technical and economic feasibility study to develop a regenerative stent for children suffering from congenital heart defects. MIT-Zuid is a program in which the 12 Dutch Provinces, the Ministry of Economic affairs and Climate, the Dutch Topsectors[…]

IMG_4244

Gerard & Anton Award for STENTiT

During the 5th edition of the Gerard and Anton Awards, STENTiT was selected as one of the top 10 most promising start-up companies to watch 2018. With this award, the jury wants to highlight start-ups in the Brainport region that have the potential to become the next Philips. According to the jury, STENTiT is providing[…]

pcr

STENTiT’s Regenerative Stent Approach at PCR Innovators Day Paris 2018.

STENTiT will present at this year’s PCR Innovators Day Paris. In a session dedicated to stents and scaffolds, the managing directors will kick-off the programme with their presentation entitled “Stentit – Regenerative stents – Minimally invasive vascular restoration”, highlighting their innovative technological approach and promising first in-vivo data. The presentation is scheduled for 16:55 CEST[…]

biomedica2-2017

Stentit Pitch At Biomedica 2017

This afternoon, dr. Sol Cabrera and dr. Sanders will present STENTiT during the short company presentation session at Biomedica 2017. In the spirit of euregional and international cooperation, the Biomedica Life Sciences Summit will bring together top researchers, innovators, and entrepreneurs from Belgium, Germany, and the Netherlands, and also from all over the globe. Its[…]

termis-bpc

STENTiT Among Top 10 European Candidates In TERMIS BPC

STENTiT is proud to announce that it has been selected among the top 10 European companies to participate in one of the largest start-up competitions in tissue engineering and regenerative medicine across Europe, the TERMIS-EU BPC. TERMIS is the world’s leading non-profit forum for academic and industrial developments within the fields of tissue engineering and[…]

innovationforhealth

STENTiT Presents at Innovation for Health

STENTiT will present its regenerative stent approach at the Innovation for Health event on the 16th of February in Rotterdam, taking part of the Innovation Pitches afternoon session. Innovation for Health is the Netherlands´ premier conference for key players in Health and Life Sciences. It brings together key players and stakeholders who play decisive parts[…]

Take Off

STW Take-Off Phase II for STENTiT

The STW Take-Off program has just closed their 5th round. STENTiT is very pleased to announce that its Take-Off Phase II application has been granted. The funding will be used to expand the R&D lines, proceed with translational studies and further grow the business. With this achievement we conclude 2016 which has been a very[…]

dutch-lifescience

STENTiT Wins Investors Forum 2016

During the Dutch Life Sciences conference in Leiden, the founders of STENTiT pitched their business plan to a group of life science investors. Among the candidates, STENTiT was unanimously chosen by the jury as the winner of the Investors Forum. In addition, STENTiT presented the case in front of a large audience during the plenary[…]

metropool-regio-eindhoven

Metropolitan Region Eindhoven Grant for STENTiT

The Metropolitan Region Eindhoven provided financial support to STENTiT in the shape of the “Stimuleringsfonds” subsidy. This funding will enable a close collaboration with regional clinical and industrial partners, to further improve the regenerative stent technology. The goal of the subsidy is to support bright ideas by giving them the financial opportunity to enhance their[…]

Biomedica

STENTiT Awarded During the Biomedica Anniversary Event

STENTiT presented the preliminary results of their regenerative stent technology last Monday by Sol Cabrera and Bart Sanders, during the 10th anniversary Biomedica Summit event in Germany. The jury acknowledged the innovative approach and awarded a cash price for being the best poster presentation in the category Medtech/Care. With around 70 large and small exhibitors[…]

Take Off

STW Take-Off Phase I Grant for STENTiT

STENTiT obtained the first pre-seed grant from the STW Take-Off program. The goal is to initiate the development of a new type of biodegradable stent for pediatric applications. The Take-Off Grant helps academic entrepreneurs with their spin-off company to make the step from an idea to a first prototype. The Take-Off instrument includes two stages;[…]